Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis

BACKGROUND AND PURPOSE: Patients treated with interferon-beta (IFN-β) can develop neutralizing antibodies (NAbs) against IFN-β that can negatively affect the therapeutic response. This study assessed the prevalence of NAbs and the impact of NAb positivity on the therapeutic response to IFN-β in Kore...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Jae-Won, Kim, Gayoung, Kim, Yeseul, Kong, Byungsoo, Joung, AeRan, Park, Na Young, Jang, Hyunmin, Shin, Hyun-June, Kim, Su-Hyun, Ahn, Suk-Won, Shin, Ha Young, Huh, So-Young, Kim, Woojun, Park, Min Su, Kim, Byung-Jo, Kim, Byoung Joon, Oh, Jeeyoung, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897201/
https://www.ncbi.nlm.nih.gov/pubmed/29504299
http://dx.doi.org/10.3988/jcn.2018.14.2.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897201/
https://www.ncbi.nlm.nih.gov/pubmed/29504299
http://dx.doi.org/10.3988/jcn.2018.14.2.186

Ejemplares similares